Can Fuzheng Huayu Capsules Reverse Liver Fibrosis

Fuzheng Huayu Capsule has the potential to reverse liver fibrosis, especially in early intervention of chronic liver disease, and is one of the important drugs for clinical anti fibrosis treatment.

Liver fibrosis is a repair response of the liver to chronic damage (such as viral hepatitis, alcoholic liver disease), and if it continues to progress, it will develop into cirrhosis. The core mechanism is the activation of hepatic stellate cells, which secrete a large amount of extracellular matrix such as collagen, leading to structural disorder of the liver. Fuzheng Huayu Capsule blocks this process through multiple targets: its active ingredients (such as Danshen and Cordyceps powder) can inhibit the activation of astrocytes and reduce collagen synthesis; At the same time, it promotes the expression of matrix metalloproteinases, accelerates the degradation of deposited collagen, thereby "softening" the liver and reversing the fibrosis process. Clinical studies have provided strong support for its therapeutic efficacy. Phase II domestic trials showed that Fuzheng Huayu Capsule alone could significantly reduce the liver hardness of patients with hepatitis B liver fibrosis, and some patients achieved pathological reversal; The Phase II trial in the United States further confirms that it is equally effective and safe for chronic hepatitis C fibrosis. However, the reversal effect of liver fibrosis is affected by the stage of the disease. Early stage patients have a higher probability of reversal after medication, while late stage liver cirrhosis patients may find it difficult to completely reverse, but Fuzheng Huayu Capsules can still delay disease progression and reduce the risk of complications. Therefore, early screening and standardized medication are key, and patients need to strictly follow medical advice and regularly evaluate liver elasticity and pathological changes.